Schedule a Vaccination | Reminder: Masks Are Still Required When Visiting
Member, Division of Bone Marrow Transplantation and Immune Deficiency
Professor, UC Department of Pediatrics
Histiocytic disorders: HLH and LCH
Better understanding histiocytic disorders and developing novel therapies for them; regulation of the immune response; immunotherapy of cancer
Cancer and Blood Diseases, Immune Deficiencies and Histiocytosis, Bone Marrow Transplantation BMT, Leukemia, Hemophagocytic lymphohistiocytosisHLH, Histiocytosis Center, Autoimmune Liver Disease, Rare Lung Diseases
Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases, Immunobiology
Michael B. Jordan, MD, Alexei A. Grom, MD3/22/2021
Michael B. Jordan, MD5/7/2020
Michael B. Jordan, MD6/28/2019
MD: UT Southwestern, Dallas, TX, 1993.
Residency: Children's Hospital of Dallas, Dallas, TX, 1996.
Fellowship: The Children's Hospital, Denver, CO, 2002.
Certification: American Board of Pediatrics, 1996; Sub-board of Pediatric Heme/Onc, 2002.
Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series.
Khandelwal, P; Teusink-Cross, A; Kumar, AR; Bleesing, JJ; Mehta, PA; Jordan, MB; Chandra, S; Davies, SM; Marsh, RA.
British Journal of Haematology.
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis.
Marsh, RA; Zoref-Lorenz, A; Owsley, E; Chaturvedi, V; Nguyen, TC; Goldman, JR; Henry, MM; Greenberg, JN; Ladisch, S; Hermiston, ML; et al.
Challenges in improving global outcomes for hemophagocytic lymphohistiocytosis.
Zoref-Lorenz, A; Jordan, MB.
Pediatric Hematology and Oncology.
Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
Ferrell, J; Sharp, S; Kumar, A; Jordan, M; Picarsic, J; Nelson, A.
Pediatric Blood and Cancer.
Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation.
Chandra, S; Chandrakasan, S; Dávila Saldaña, BJ; Bleesing, JJ; Jordan, MB; Kumar, AR; Grimley, MS; Krupski, C; Davies, SM; Khandelwal, P; et al.
Journal of Clinical Immunology.
Possible roads to improve hemophagocytic lymphohistiocytosis outcome.
Merli, P; Jordan, MB; Locatelli, F.
Multiplexed Functional Assessment of Genetic Variants in CARD11.
Meitlis, I; Allenspach, EJ; Bauman, BM; Phan, IQ; Dabbah, G; Schmitt, EG; Camp, ND; Torgerson, TR; Nickerson, DA; Bamshad, MJ; et al.
American Journal of Human Genetics.
A tribute to the life and work of Alexandra (Lisa) H. Filipovich, 1951-2020.
Davies, SM; Jordan, MB; Marsh, R.
Pediatric Blood and Cancer.
Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. Reply.
Jordan, MB; Locatelli, F.
New England Journal of Medicine.
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al.
Bone Marrow Transplantation.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2021 Cincinnati Children's Hospital Medical Center. All rights reserved.